| Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
|---|
| lanthanum | [no description available] | medium | 396 | 2 | f-block element atom;
lanthanoid atom;
scandium group element atom | |
| uranium | [no description available] | medium | 1 | 0 | actinoid atom;
f-block element atom;
monoatomic uranium | |
| edetic acid | [no description available] | medium | 8 | 0 | ethylenediamine derivative;
polyamino carboxylic acid;
tetracarboxylic acid | anticoagulant;
antidote;
chelator;
copper chelator;
geroprotector |
| oligonucleotides | [no description available] | medium | 1 | 0 | | |
| fumonisin b1 | [no description available] | medium | 1 | 0 | diester;
fumonisin;
primary amino compound;
triol | carcinogenic agent;
metabolite |
| aflatoxin b1 | [no description available] | medium | 1 | 0 | aflatoxin;
aromatic ether;
aromatic ketone | carcinogenic agent;
human metabolite |
| lanthanum carbonate | [no description available] | medium | 6 | 1 | | |
| phosphorus | [no description available] | medium | 3 | 0 | monoatomic phosphorus;
nonmetal atom;
pnictogen | macronutrient |
| calcimycin | [no description available] | medium | 19 | 0 | benzoxazole | |
| butyric acid | [no description available] | medium | 2 | 0 | fatty acid 4:0;
straight-chain saturated fatty acid | human urinary metabolite;
Mycoplasma genitalium metabolite |
| acrolein | [no description available] | medium | 1 | 0 | enal | herbicide;
human xenobiotic metabolite;
toxin |
| egtazic acid | [no description available] | medium | 44 | 0 | diether;
tertiary amino compound;
tetracarboxylic acid | chelator |
| tyramine | [no description available] | medium | 1 | 0 | monoamine molecular messenger;
primary amino compound;
tyramines | EC 3.1.1.8 (cholinesterase) inhibitor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter |
| gamma-aminobutyric acid | [no description available] | medium | 4 | 0 | amino acid zwitterion;
gamma-amino acid;
monocarboxylic acid | human metabolite;
neurotransmitter;
Saccharomyces cerevisiae metabolite;
signalling molecule |
| tetrodotoxin | [no description available] | medium | 5 | 0 | azatetracycloalkane;
oxatetracycloalkane;
quinazoline alkaloid | animal metabolite;
bacterial metabolite;
marine metabolite;
neurotoxin;
voltage-gated sodium channel blocker |
| vanadyl sulfate | [no description available] | medium | 1 | 0 | metal sulfate;
vanadium coordination entity | |
| 2,5-dihydroxybenzoic acid | [no description available] | medium | 1 | 0 | dihydroxybenzoic acid | EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
fungal metabolite;
human metabolite;
MALDI matrix material;
mouse metabolite |
| verapamil | [no description available] | medium | 25 | 0 | aromatic ether;
nitrile;
polyether;
tertiary amino compound | |
| alpha-chlorohydrin | [no description available] | medium | 1 | 0 | chloropropane-1,2-diol | |
| lactic acid | [no description available] | medium | 2 | 0 | 2-hydroxy monocarboxylic acid | algal metabolite;
Daphnia magna metabolite |
| glycogen | [no description available] | medium | 2 | 0 | | |
| phosphorylcholine | [no description available] | medium | 1 | 0 | phosphocholines | allergen;
epitope;
hapten;
human metabolite;
mouse metabolite |
| chlorhexidine | [no description available] | medium | 1 | 0 | biguanides;
monochlorobenzenes | antibacterial agent;
antiinfective agent |
| pd 98059 | [no description available] | medium | 1 | 0 | aromatic amine;
monomethoxyflavone | EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector |
| fluo-3 | [no description available] | medium | 1 | 0 | xanthene dye | fluorochrome |
| xanthenes | [no description available] | medium | 2 | 0 | xanthene | |
| dimethyl sulfoxide | [no description available] | medium | 2 | 0 | sulfoxide;
volatile organic compound | alkylating agent;
antidote;
Escherichia coli metabolite;
geroprotector;
MRI contrast agent;
non-narcotic analgesic;
polar aprotic solvent;
radical scavenger |
| tacrolimus | [no description available] | medium | 1 | 0 | macrolide lactam | bacterial metabolite;
immunosuppressive agent |
| fg 9041 | [no description available] | medium | 1 | 0 | quinoxaline derivative | |
| pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid | [no description available] | medium | 1 | 0 | arenesulfonic acid;
azobenzenes;
methylpyridines;
monohydroxypyridine;
organic phosphate;
pyridinecarbaldehyde | purinergic receptor P2X antagonist |
| gadolinium chloride | [no description available] | medium | 11 | 0 | gadolinium coordination entity | TRP channel blocker |
| gadolinium | [no description available] | medium | 12 | 0 | f-block element atom;
lanthanoid atom | |
| 2-amino-5-phosphonovalerate | [no description available] | medium | 3 | 0 | non-proteinogenic alpha-amino acid | NMDA receptor antagonist |
| bicuculline | [no description available] | medium | 1 | 0 | benzylisoquinoline alkaloid;
isoquinoline alkaloid;
isoquinolines | agrochemical;
central nervous system stimulant;
GABA-gated chloride channel antagonist;
GABAA receptor antagonist;
neurotoxin |
| probenecid | [no description available] | medium | 1 | 0 | benzoic acids;
sulfonamide | uricosuric drug |
| strychnine | [no description available] | medium | 1 | 0 | monoterpenoid indole alkaloid;
organic heteroheptacyclic compound | avicide;
cholinergic antagonist;
glycine receptor antagonist;
neurotransmitter agent;
rodenticide |
| pyridoxal phosphate | [no description available] | medium | 1 | 0 | methylpyridines;
monohydroxypyridine;
pyridinecarbaldehyde;
vitamin B6 phosphate | coenzyme;
cofactor;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite |
| valine | [no description available] | medium | 2 | 0 | L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid;
valine | algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite |
| quinoxalines | [no description available] | medium | 2 | 0 | mancude organic heterobicyclic parent;
naphthyridine;
ortho-fused heteroarene | |
| fluorocitrate | [no description available] | medium | 1 | 0 | carbonyl compound | |
| holmium | [no description available] | medium | 2 | 0 | f-block element atom;
lanthanoid atom | |
| yttrium | [no description available] | medium | 3 | 0 | d-block element atom;
rare earth metal atom;
scandium group element atom | |
| thiourea | [no description available] | medium | 5 | 0 | one-carbon compound;
thioureas;
ureas | antioxidant;
chromophore |
| sodium borohydride | [no description available] | medium | 1 | 0 | inorganic sodium salt;
metal tetrahydridoborate | |
| mercury | [no description available] | medium | 2 | 0 | elemental mercury;
zinc group element atom | neurotoxin |
| cerium | [no description available] | medium | 10 | 1 | f-block element atom;
lanthanoid atom | |
| cerous chloride | [no description available] | medium | 5 | 0 | cerium coordination entity | |
| imidazole | [no description available] | medium | 1 | 0 | imidazole | |
| jasmonic acid | [no description available] | medium | 3 | 0 | oxo monocarboxylic acid | jasmonates;
plant metabolite |
| cyclopentane | [no description available] | medium | 5 | 0 | cycloalkane;
cyclopentanes;
volatile organic compound | non-polar solvent |
| phenyl acetate | [no description available] | medium | 4 | 0 | benzenes;
phenyl acetates | |
| abscisic acid | [no description available] | medium | 4 | 0 | 2-trans-abscisic acid | |
| methyl jasmonate | [no description available] | medium | 2 | 0 | | |
| calcium acetate | [no description available] | medium | 1 | 0 | calcium salt | chelator |
| tetraethylammonium | [no description available] | medium | 6 | 0 | quaternary ammonium ion | |
| propyl gallate | [no description available] | medium | 1 | 0 | trihydroxybenzoic acid | |
| ethylene | [no description available] | medium | 5 | 0 | alkene;
gas molecular entity | plant hormone;
refrigerant |
| silver nitrate | [no description available] | medium | 2 | 0 | inorganic nitrate salt;
silver salt | astringent |
| vanadates | [no description available] | medium | 10 | 0 | trivalent inorganic anion;
vanadium oxoanion | EC 3.1.3.1 (alkaline phosphatase) inhibitor;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor |
| caloxin 2a1 | [no description available] | medium | 1 | 0 | | |
| methane | [no description available] | medium | 1 | 0 | alkane;
gas molecular entity;
mononuclear parent hydride;
one-carbon compound | bacterial metabolite;
fossil fuel;
greenhouse gas |
| aluminum oxide | [no description available] | medium | 1 | 0 | | |
| praseodymium | [no description available] | medium | 1 | 1 | f-block element atom;
lanthanoid atom | |
| mercuric chloride | [no description available] | medium | 2 | 0 | mercury coordination entity | sensitiser |
| salicylhydroxamic acid | [no description available] | medium | 1 | 0 | hydroxamic acid;
phenols | antibacterial drug;
EC 1.11.2.2 (myeloperoxidase) inhibitor;
EC 3.5.1.5 (urease) inhibitor;
trypanocidal drug |
| mannose | [no description available] | medium | 1 | 0 | D-aldohexose;
D-mannose;
mannopyranose | metabolite |
| diphenyleneiodonium | [no description available] | medium | 4 | 0 | organic cation | |
| ibuprofen | [no description available] | medium | 2 | 0 | monocarboxylic acid | antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
radical scavenger;
xenobiotic |
| fura-2 | [no description available] | medium | 9 | 0 | | |
| n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine | [no description available] | medium | 2 | 0 | N-substituted diamine;
pyridines;
tertiary amino compound | apoptosis inducer;
chelator;
copper chelator |
| 2-aminoethoxydiphenyl borate | [no description available] | medium | 3 | 0 | organoboron compound;
primary amino compound | calcium channel blocker;
IP3 receptor antagonist;
potassium channel opener |
| chlorophyll a | [no description available] | medium | 3 | 0 | chlorophyll;
methyl ester | cofactor |
| sodium tungstate(vi) | [no description available] | medium | 1 | 0 | inorganic sodium salt | reagent |
| ng-nitroarginine methyl ester | [no description available] | medium | 1 | 0 | alpha-amino acid ester;
L-arginine derivative;
methyl ester;
N-nitro compound | EC 1.14.13.39 (nitric oxide synthase) inhibitor |
| 1,3-dimethylthiourea | [no description available] | medium | 1 | 0 | | |
| framycetin | [no description available] | medium | 3 | 0 | aminoglycoside | allergen;
antibacterial drug;
Escherichia coli metabolite |
| ethidium | [no description available] | medium | 2 | 0 | phenanthridines | fluorochrome;
intercalator |
| glucose, (beta-d)-isomer | [no description available] | medium | 1 | 0 | D-glucopyranose | epitope;
mouse metabolite |
| dapagliflozin | [no description available] | medium | 1 | 0 | aromatic ether;
C-glycosyl compound;
monochlorobenzenes | hypoglycemic agent;
sodium-glucose transport protein subtype 2 inhibitor |
| octacalcium phosphate | [no description available] | medium | 1 | 0 | | |
| durapatite | [no description available] | medium | 2 | 0 | | |
| calcium phosphate, dibasic, dihydrate | [no description available] | medium | 1 | 0 | calcium salt;
hydrate | |
| tricalcium phosphate | [no description available] | medium | 2 | 0 | calcium phosphate | |
| deuterium | [no description available] | medium | 1 | 0 | dihydrogen | |
| chlorine | [no description available] | medium | 14 | 0 | halide anion;
monoatomic chlorine | cofactor;
Escherichia coli metabolite;
human metabolite |
| caprolactone | [no description available] | medium | 1 | 0 | epsilon-lactone | |
| titanium | [no description available] | medium | 1 | 0 | titanium group element atom | |
| mocetinostat | [no description available] | medium | 1 | 0 | aminopyrimidine;
benzamides;
pyridines;
secondary amino compound;
secondary carboxamide;
substituted aniline | antineoplastic agent;
apoptosis inducer;
autophagy inducer;
cardioprotective agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
hepatotoxic agent |
| nitrates | [no description available] | medium | 2 | 0 | monovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species | |
| thiazolyl blue | [no description available] | medium | 1 | 0 | organic bromide salt | colorimetric reagent;
dye |
| thiazoles | [no description available] | medium | 2 | 0 | 1,3-thiazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene | |
| oxadiazoles | [no description available] | medium | 2 | 0 | | |
| 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one | [no description available] | medium | 1 | 0 | oxadiazoloquinoxaline | EC 4.6.1.2 (guanylate cyclase) inhibitor |
| ciglitazone | [no description available] | medium | 1 | 0 | aromatic ether;
thiazolidinone | antineoplastic agent;
insulin-sensitizing drug |
| 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | [no description available] | medium | 1 | 0 | chromanol;
monocarboxylic acid;
phenols | antioxidant;
ferroptosis inhibitor;
neuroprotective agent;
radical scavenger;
Wnt signalling inhibitor |
| neodymium chloride | [no description available] | medium | 7 | 0 | | |
| neodymium | [no description available] | medium | 7 | 0 | f-block element atom;
lanthanoid atom | |
| isoxazoles | [no description available] | medium | 1 | 0 | isoxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene | |
| fluorexon | [no description available] | medium | 1 | 0 | xanthene dye | fluorochrome |
| erythrosine | [no description available] | medium | 4 | 0 | | |
| safingol | [no description available] | medium | 1 | 0 | amino alcohol | |
| dizocilpine maleate | [no description available] | medium | 1 | 0 | maleate salt;
tetracyclic antidepressant | anaesthetic;
anticonvulsant;
neuroprotective agent;
nicotinic antagonist;
NMDA receptor antagonist |
| sphingosine | [no description available] | medium | 2 | 0 | sphing-4-enine | human metabolite;
mouse metabolite |
| potassium chloride | [no description available] | medium | 16 | 0 | inorganic chloride;
inorganic potassium salt;
potassium salt | fertilizer |
| cadmium chloride | [no description available] | medium | 5 | 0 | cadmium coordination entity | |
| pyrrolidonecarboxylic acid | [no description available] | medium | 1 | 0 | 5-oxoproline;
L-proline derivative;
non-proteinogenic L-alpha-amino acid | algal metabolite |
| gabapentin | [no description available] | medium | 1 | 0 | gamma-amino acid | anticonvulsant;
calcium channel blocker;
environmental contaminant;
xenobiotic |
| ouabain | [no description available] | medium | 6 | 0 | 11alpha-hydroxy steroid;
14beta-hydroxy steroid;
5beta-hydroxy steroid;
alpha-L-rhamnoside;
cardenolide glycoside;
steroid hormone | anti-arrhythmia drug;
cardiotonic drug;
EC 2.3.3.1 [citrate (Si)-synthase] inhibitor;
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
ion transport inhibitor;
plant metabolite |
| snx 230 | [no description available] | medium | 1 | 0 | | |
| cyclin d1 | [no description available] | medium | 1 | 0 | | |
| okadaic acid | [no description available] | medium | 2 | 0 | ketal | |
| nifedipine | [no description available] | medium | 14 | 0 | C-nitro compound;
dihydropyridine;
methyl ester | calcium channel blocker;
human metabolite;
tocolytic agent;
vasodilator agent |
| hydrogen carbonate | [no description available] | medium | 1 | 0 | carbon oxoanion | cofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite |
| n-tetradecane | [no description available] | medium | 1 | 0 | long-chain alkane | plant metabolite;
volatile oil component |
| 1,2-dipalmitoylphosphatidylcholine | [no description available] | medium | 1 | 0 | | |
| glutamic acid | [no description available] | medium | 8 | 0 | glutamic acid;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid | Escherichia coli metabolite;
ferroptosis inducer;
micronutrient;
mouse metabolite;
neurotransmitter;
nutraceutical |
| fusicoccin | [no description available] | medium | 2 | 0 | | |
| glycosides | [no description available] | medium | 3 | 0 | | |
| aluminum | [no description available] | medium | 3 | 0 | boron group element atom;
elemental aluminium;
metal atom | |
| phenylglyoxal | [no description available] | medium | 1 | 0 | phenylacetaldehydes | |
| oxalates | [no description available] | medium | 1 | 0 | | |
| fura-2-am | [no description available] | medium | 1 | 0 | | |
| flufenamic acid | [no description available] | medium | 2 | 0 | aromatic amino acid;
organofluorine compound | antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug |
| bradykinin | [no description available] | medium | 7 | 0 | oligopeptide | human blood serum metabolite;
vasodilator agent |
| cytochrome c-t | [no description available] | medium | 2 | 0 | | |
| capsaicin | [no description available] | medium | 3 | 0 | capsaicinoid | non-narcotic analgesic;
TRPV1 agonist;
voltage-gated sodium channel blocker |
| beta-glycerophosphoric acid | [no description available] | medium | 1 | 0 | glycerol monophosphate | Escherichia coli metabolite;
plant metabolite |
| stannic oxide | [no description available] | medium | 1 | 0 | tin oxide | |
| hypochlorous acid | [no description available] | medium | 1 | 0 | chlorine oxoacid;
reactive oxygen species | EC 2.5.1.18 (glutathione transferase) inhibitor;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
human metabolite |
| baicalin | [no description available] | medium | 1 | 0 | dihydroxyflavone;
glucosiduronic acid;
glycosyloxyflavone;
monosaccharide derivative | antiatherosclerotic agent;
antibacterial agent;
anticoronaviral agent;
antineoplastic agent;
antioxidant;
cardioprotective agent;
EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
ferroptosis inhibitor;
neuroprotective agent;
non-steroidal anti-inflammatory drug;
plant metabolite;
prodrug |
| cadmium | [no description available] | medium | 4 | 0 | cadmium molecular entity;
zinc group element atom | |
| 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole | [no description available] | medium | 1 | 0 | benzoic acid;
imidazolines;
organic radical | apoptosis inhibitor;
radical scavenger |
| phytosphingosine | [no description available] | medium | 1 | 0 | amino alcohol;
sphingoid;
triol | mouse metabolite;
Saccharomyces cerevisiae metabolite |
| erythritol | [no description available] | medium | 1 | 0 | butane-1,2,3,4-tetrol | antioxidant;
human metabolite;
plant metabolite |
| dithionitrobenzoic acid | [no description available] | medium | 1 | 0 | nitrobenzoic acid;
organic disulfide | indicator |
| urea | [no description available] | medium | 2 | 0 | isourea;
monocarboxylic acid amide;
one-carbon compound | Daphnia magna metabolite;
Escherichia coli metabolite;
fertilizer;
flour treatment agent;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite |
| zinc oxide | [no description available] | medium | 1 | 0 | zinc molecular entity | |
| carbon monoxide | [no description available] | medium | 1 | 0 | carbon oxide;
gas molecular entity;
one-carbon compound | biomarker;
EC 1.9.3.1 (cytochrome c oxidase) inhibitor;
human metabolite;
ligand;
metabolite;
mitochondrial respiratory-chain inhibitor;
mouse metabolite;
neurotoxin;
neurotransmitter;
P450 inhibitor;
probe;
signalling molecule;
vasodilator agent |
| sesquiterpenes | [no description available] | medium | 1 | 0 | | |
| inositol 1,4,5-trisphosphate | [no description available] | medium | 6 | 0 | myo-inositol trisphosphate | mouse metabolite |
| r 59022 | [no description available] | medium | 1 | 0 | diarylmethane | |
| phosphorus radioisotopes | [no description available] | medium | 1 | 0 | | |
| pyrimidinones | [no description available] | medium | 2 | 0 | | |
| malondialdehyde | [no description available] | medium | 2 | 0 | dialdehyde | biomarker |
| tropolone | [no description available] | medium | 1 | 0 | alpha-hydroxy ketone;
cyclic ketone;
enol | bacterial metabolite;
fungicide;
toxin |
| mastoparan | [no description available] | medium | 1 | 0 | mastoparans;
peptidyl amide | antimicrobial agent |
| beta-thujaplicin | [no description available] | medium | 1 | 0 | cyclic ketone;
enol;
monoterpenoid | antibacterial agent;
antifungal agent;
antineoplastic agent;
antiplasmodial drug;
plant metabolite |
| suramin | [no description available] | medium | 2 | 0 | naphthalenesulfonic acid;
phenylureas;
secondary carboxamide | angiogenesis inhibitor;
antinematodal drug;
antineoplastic agent;
apoptosis inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
GABA antagonist;
GABA-gated chloride channel antagonist;
purinergic receptor P2 antagonist;
ryanodine receptor agonist;
trypanocidal drug |
| cycloheximide | [no description available] | medium | 3 | 0 | antibiotic fungicide;
cyclic ketone;
dicarboximide;
piperidine antibiotic;
piperidones;
secondary alcohol | anticoronaviral agent;
bacterial metabolite;
ferroptosis inhibitor;
neuroprotective agent;
protein synthesis inhibitor |
| valinomycin | [no description available] | medium | 2 | 0 | cyclodepsipeptide;
macrocycle | antimicrobial agent;
antiviral agent;
bacterial metabolite;
potassium ionophore |
| inositol 1,4,5-trisphosphate 1-(2-nitrophenyl)ethyl ester | [no description available] | medium | 1 | 0 | | |
| sodium glutamate | [no description available] | medium | 2 | 0 | monosodium glutamate | flavouring agent |
| thapsigargin | [no description available] | medium | 10 | 0 | butyrate ester;
organic heterotricyclic compound;
sesquiterpene lactone | calcium channel blocker;
EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor |
| oxazoles | [no description available] | medium | 2 | 0 | 1,3-oxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene | |
| xestospongin a | [no description available] | medium | 2 | 0 | | |
| leukotoxin | [no description available] | medium | 1 | 0 | | |
| galactitol | [no description available] | medium | 2 | 0 | hexitol | Escherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite |
| ryanodine | [no description available] | medium | 1 | 0 | | |
| niflumic acid | [no description available] | medium | 2 | 0 | aromatic carboxylic acid;
pyridines | |
| 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole | [no description available] | medium | 6 | 0 | ether;
imidazoles;
monomethoxybenzene | TRP channel blocker |
| nickel chloride | [no description available] | medium | 5 | 0 | nickel coordination entity | calcium channel blocker;
hapten |
| nickel | [no description available] | medium | 5 | 0 | metal allergen;
nickel group element atom | epitope;
micronutrient |
| nitric acid | [no description available] | medium | 1 | 0 | nitrogen oxoacid | protic solvent;
reagent |
| trifluoperazine | [no description available] | medium | 6 | 0 | N-alkylpiperazine;
N-methylpiperazine;
organofluorine compound;
phenothiazines | antiemetic;
calmodulin antagonist;
dopaminergic antagonist;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor;
phenothiazine antipsychotic drug |
| chlorpromazine | [no description available] | medium | 4 | 0 | organochlorine compound;
phenothiazines;
tertiary amine | anticoronaviral agent;
antiemetic;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
phenothiazine antipsychotic drug |
| phentolamine | [no description available] | medium | 1 | 0 | imidazoles;
phenols;
substituted aniline;
tertiary amino compound | alpha-adrenergic antagonist;
vasodilator agent |
| mibefradil | [no description available] | medium | 1 | 0 | tetralins | T-type calcium channel blocker |
| pimozide | [no description available] | medium | 1 | 0 | benzimidazoles;
heteroarylpiperidine;
organofluorine compound | antidyskinesia agent;
dopaminergic antagonist;
first generation antipsychotic;
H1-receptor antagonist;
serotonergic antagonist |
| calciseptine | [no description available] | medium | 1 | 0 | | |
| snx 482 | [no description available] | medium | 1 | 0 | | |
| ziconotide | [no description available] | medium | 1 | 0 | | |
| omega-agatoxin iva | [no description available] | medium | 1 | 0 | | |
| cesium | [no description available] | medium | 1 | 0 | alkali metal atom | |
| chlorine | [no description available] | medium | 2 | 0 | diatomic chlorine;
gas molecular entity | bleaching agent |
| cesium chloride | [no description available] | medium | 1 | 0 | inorganic caesium salt;
inorganic chloride | phase-transfer catalyst;
vasoconstrictor agent |
| ribose | [no description available] | medium | 1 | 0 | D-ribose;
ribopyranose | |
| pyridine | [no description available] | medium | 1 | 0 | azaarene;
mancude organic heteromonocyclic parent;
monocyclic heteroarene;
pyridines | environmental contaminant;
NMR chemical shift reference compound |
| (3,4-dihydroxyphenylamino)-2-imidazoline | [no description available] | medium | 1 | 0 | | |
| acetylcysteine | [no description available] | medium | 1 | 0 | acetylcysteine;
L-cysteine derivative;
N-acetyl-L-amino acid | antidote to paracetamol poisoning;
antiinfective agent;
antioxidant;
antiviral drug;
ferroptosis inhibitor;
geroprotector;
human metabolite;
mucolytic;
radical scavenger;
vulnerary |
| ascorbic acid | [no description available] | medium | 2 | 0 | ascorbic acid;
vitamin C | coenzyme;
cofactor;
flour treatment agent;
food antioxidant;
food colour retention agent;
geroprotector;
plant metabolite;
skin lightening agent |
| 1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt | [no description available] | medium | 1 | 0 | organic molecular entity | |
| carbachol | [no description available] | medium | 6 | 0 | ammonium salt;
carbamate ester | cardiotonic drug;
miotic;
muscarinic agonist;
nicotinic acetylcholine receptor agonist;
non-narcotic analgesic |
| colforsin | [no description available] | medium | 4 | 0 | acetate ester;
cyclic ketone;
labdane diterpenoid;
organic heterotricyclic compound;
tertiary alpha-hydroxy ketone;
triol | adenylate cyclase agonist;
anti-HIV agent;
antihypertensive agent;
plant metabolite;
platelet aggregation inhibitor;
protein kinase A agonist |
| 1-methyl-3-isobutylxanthine | [no description available] | medium | 3 | 0 | 3-isobutyl-1-methylxanthine | |
| gibberellins | [no description available] | medium | 2 | 0 | | |
| gibberellic acid | [no description available] | medium | 2 | 0 | C19-gibberellin;
gibberellin monocarboxylic acid;
lactone;
organic heteropentacyclic compound | mouse metabolite;
plant metabolite |
| strontium | [no description available] | medium | 2 | 0 | alkaline earth metal atom | |
| propionic acid | [no description available] | medium | 2 | 0 | saturated fatty acid;
short-chain fatty acid | antifungal drug |
| heme | [no description available] | medium | 1 | 0 | | |
| methanol | [no description available] | medium | 1 | 0 | alkyl alcohol;
one-carbon compound;
primary alcohol;
volatile organic compound | amphiprotic solvent;
Escherichia coli metabolite;
fuel;
human metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite |
| sulforhodamine 101 | [no description available] | medium | 1 | 0 | organic heteroheptacyclic compound | fluorochrome |
| carbenoxolone sodium | [no description available] | medium | 2 | 0 | triterpenoid | |
| bucladesine | [no description available] | medium | 3 | 0 | 3',5'-cyclic purine nucleotide | |
| digitonin | [no description available] | medium | 1 | 0 | | |
| cytochalasin d | [no description available] | medium | 2 | 0 | | |
| sq-23377 | [no description available] | medium | 3 | 0 | cyclic ether;
enol;
polyunsaturated fatty acid;
very long-chain fatty acid | calcium ionophore;
metabolite |
| cysteine | [no description available] | medium | 2 | 0 | cysteinium | fundamental metabolite |
| clay | [no description available] | medium | 1 | 0 | | |
| naproxen | [no description available] | medium | 1 | 0 | methoxynaphthalene;
monocarboxylic acid | antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
gout suppressant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic |
| dantrolene | [no description available] | medium | 2 | 0 | hydrazone;
imidazolidine-2,4-dione | muscle relaxant;
neuroprotective agent;
ryanodine receptor antagonist |
| kb r7943 | [no description available] | medium | 1 | 0 | | |
| bisindolylmaleimide i | [no description available] | medium | 1 | 0 | | |
| loe 908 | [no description available] | medium | 1 | 0 | | |
| u 73122 | [no description available] | medium | 1 | 0 | aromatic ether;
aza-steroid;
maleimides | EC 3.1.4.11 (phosphoinositide phospholipase C) inhibitor |
| ym-254890 | [no description available] | medium | 1 | 0 | | |
| calixarenes | [no description available] | medium | 1 | 0 | | |
| systemin | [no description available] | medium | 1 | 0 | | |
| staurosporine aglycone | [no description available] | medium | 2 | 0 | | |
| dehydroascorbic acid | [no description available] | medium | 1 | 0 | dehydroascorbic acid;
vitamin C | coenzyme;
mouse metabolite |
| maitotoxin | [no description available] | medium | 1 | 0 | | |
| nystatin a1 | [no description available] | medium | 1 | 0 | nystatins | |
| gold | [no description available] | medium | 1 | 0 | copper group element atom;
elemental gold | |
| decyltrimethylammonium | [no description available] | medium | 1 | 0 | quaternary ammonium ion | |
| hafnium | [no description available] | medium | 1 | 0 | titanium group element atom | |
| 2-propanol | [no description available] | medium | 1 | 0 | secondary alcohol;
secondary fatty alcohol | protic solvent |
| methyl oleate | [no description available] | medium | 1 | 0 | fatty acid methyl ester | |
| lithium | [no description available] | medium | 4 | 0 | alkali metal atom | |
| 4-chloromercuribenzenesulfonate | [no description available] | medium | 1 | 0 | arenesulfonic acid;
arylmercury compound | |
| phloretin | [no description available] | medium | 1 | 0 | dihydrochalcones | antineoplastic agent;
plant metabolite |
| 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid | [no description available] | medium | 3 | 0 | | |
| 4-acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid | [no description available] | medium | 3 | 0 | stilbenoid | |
| cyclic gmp | [no description available] | medium | 2 | 0 | 3',5'-cyclic purine nucleotide;
guanyl ribonucleotide | Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite |
| quinacrine | [no description available] | medium | 2 | 0 | acridines;
aromatic ether;
organochlorine compound;
tertiary amino compound | antimalarial;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor |
| 8-bromocyclic gmp | [no description available] | medium | 1 | 0 | 3',5'-cyclic purine nucleotide;
organobromine compound | muscle relaxant;
protein kinase G agonist |
| cromolyn sodium | [no description available] | medium | 1 | 0 | organic sodium salt | anti-asthmatic drug;
drug allergen |
| indomethacin | [no description available] | medium | 1 | 0 | aromatic ether;
indole-3-acetic acids;
monochlorobenzenes;
N-acylindole | analgesic;
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
gout suppressant;
non-steroidal anti-inflammatory drug;
xenobiotic metabolite;
xenobiotic |
| kainic acid | [no description available] | medium | 2 | 0 | dicarboxylic acid;
L-proline derivative;
non-proteinogenic L-alpha-amino acid;
pyrrolidinecarboxylic acid | antinematodal drug;
excitatory amino acid agonist |
| glutamic acid diethyl ester | [no description available] | medium | 1 | 0 | | |
| angiotensin ii | [no description available] | medium | 3 | 0 | amino acid zwitterion;
angiotensin II | human metabolite |
| phenylephrine | [no description available] | medium | 2 | 0 | phenols;
phenylethanolamines;
secondary amino compound | alpha-adrenergic agonist;
cardiotonic drug;
mydriatic agent;
nasal decongestant;
protective agent;
sympathomimetic agent;
vasoconstrictor agent |
| pituitrin | [no description available] | medium | 2 | 0 | | |
| concanavalin a | [no description available] | medium | 3 | 0 | | |
| dicyclohexylcarbodiimide | [no description available] | medium | 1 | 0 | carbodiimide | ATP synthase inhibitor;
cross-linking reagent;
peptide coupling reagent |
| glutathione disulfide | [no description available] | medium | 1 | 0 | glutathione derivative;
organic disulfide | Escherichia coli metabolite;
mouse metabolite |
| manganese | [no description available] | medium | 9 | 0 | elemental manganese;
manganese group element atom | Escherichia coli metabolite;
micronutrient |
| clonidine | [no description available] | medium | 1 | 0 | clonidine;
imidazoline | |
| isoproterenol | [no description available] | medium | 3 | 0 | catechols;
secondary alcohol;
secondary amino compound | beta-adrenergic agonist;
bronchodilator agent;
cardiotonic drug;
sympathomimetic agent |
| cinnarizine | [no description available] | medium | 1 | 0 | diarylmethane;
N-alkylpiperazine;
olefinic compound | anti-allergic agent;
antiemetic;
calcium channel blocker;
geroprotector;
H1-receptor antagonist;
histamine antagonist;
muscarinic antagonist |
| diltiazem | [no description available] | medium | 8 | 0 | 5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate | antihypertensive agent;
calcium channel blocker;
vasodilator agent |
| flunarizine | [no description available] | medium | 2 | 0 | diarylmethane | |
| acetylthiocholine | [no description available] | medium | 1 | 0 | | |
| carbamates | [no description available] | medium | 1 | 0 | amino-acid anion | |
| evans blue | [no description available] | medium | 1 | 0 | organic sodium salt | fluorochrome;
histological dye;
sodium channel blocker;
teratogenic agent |
| enkephalin, leucine-2-alanine | [no description available] | medium | 1 | 0 | | |
| enkephalin, leucine | [no description available] | medium | 2 | 0 | pentapeptide;
peptide zwitterion | analgesic;
delta-opioid receptor agonist;
human metabolite;
mu-opioid receptor agonist;
neurotransmitter;
rat metabolite |
| fluorescein-5-isothiocyanate | [no description available] | medium | 1 | 0 | fluorescein isothiocyanate | |
| isradipine | [no description available] | medium | 2 | 0 | benzoxadiazole;
dihydropyridine;
isopropyl ester;
methyl ester | |
| barium chloride | [no description available] | medium | 2 | 0 | barium salt;
inorganic chloride | potassium channel blocker |
| 1,4-dihydropyridine | [no description available] | medium | 3 | 0 | | |
| bay-k-8644 | [no description available] | medium | 4 | 0 | (trifluoromethyl)benzenes;
C-nitro compound;
dihydropyridine;
methyl ester | |
| dihydropyridines | [no description available] | medium | 4 | 0 | | |
| prostaglandin d2 | [no description available] | medium | 1 | 0 | prostaglandins D | human metabolite;
mouse metabolite |
| theophylline | [no description available] | medium | 2 | 0 | dimethylxanthine | adenosine receptor antagonist;
anti-asthmatic drug;
anti-inflammatory agent;
bronchodilator agent;
drug metabolite;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
fungal metabolite;
human blood serum metabolite;
immunomodulator;
muscle relaxant;
vasodilator agent |
| n-pentanoic acid | [no description available] | medium | 1 | 0 | short-chain fatty acid;
straight-chain saturated fatty acid | plant metabolite |
| sodium fluoride | [no description available] | medium | 1 | 0 | fluoride salt | mutagen |
| 1,2-bis(2-aminophenoxy)ethane n,n,n',n'-tetraacetic acid acetoxymethyl ester | [no description available] | medium | 2 | 0 | | |
| zinc chloride | [no description available] | medium | 2 | 0 | inorganic chloride;
zinc molecular entity | astringent;
disinfectant;
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor;
Lewis acid |
| tamoxifen | [no description available] | medium | 1 | 0 | stilbenoid;
tertiary amino compound | angiogenesis inhibitor;
antineoplastic agent;
bone density conservation agent;
EC 1.2.3.1 (aldehyde oxidase) inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
estrogen antagonist;
estrogen receptor antagonist;
estrogen receptor modulator |
| 7-oxoprostaglandin i2 | [no description available] | medium | 1 | 0 | | |
| amanitins | [no description available] | medium | 1 | 0 | | |
| menthol | [no description available] | medium | 1 | 0 | p-menthane monoterpenoid;
secondary alcohol | volatile oil component |
| ammonium chloride | [no description available] | medium | 4 | 0 | ammonium salt;
inorganic chloride | ferroptosis inhibitor |
| nicotine | [no description available] | medium | 1 | 0 | 3-(1-methylpyrrolidin-2-yl)pyridine | anxiolytic drug;
biomarker;
immunomodulator;
mitogen;
neurotoxin;
nicotinic acetylcholine receptor agonist;
peripheral nervous system drug;
phytogenic insecticide;
plant metabolite;
psychotropic drug;
teratogenic agent;
xenobiotic |
| cobalt | [no description available] | medium | 7 | 0 | cobalt group element atom;
metal allergen | micronutrient |
| cobaltous chloride | [no description available] | medium | 6 | 0 | cobalt salt;
inorganic chloride | allergen;
calcium channel blocker;
sensitiser;
two-colour indicator |
| fluorides | [no description available] | medium | 2 | 0 | halide anion;
monoatomic fluorine | |
| aluminum fluoride | [no description available] | medium | 1 | 0 | aluminium coordination entity | |
| folic acid | [no description available] | medium | 1 | 0 | folic acids;
N-acyl-amino acid | human metabolite;
mouse metabolite;
nutrient |
| chlortetracycline | [no description available] | medium | 1 | 0 | | |
| genistein | [no description available] | medium | 1 | 0 | 7-hydroxyisoflavones | antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
human urinary metabolite;
phytoestrogen;
plant metabolite;
tyrosine kinase inhibitor |
| histamine | [no description available] | medium | 1 | 0 | aralkylamino compound;
imidazoles | human metabolite;
mouse metabolite;
neurotransmitter |
| arachidonic acid | [no description available] | medium | 2 | 0 | icosa-5,8,11,14-tetraenoic acid;
long-chain fatty acid;
omega-6 fatty acid | Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
human metabolite;
mouse metabolite |
| ethacrynic acid | [no description available] | medium | 1 | 0 | aromatic ether;
aromatic ketone;
dichlorobenzene;
monocarboxylic acid | EC 2.5.1.18 (glutathione transferase) inhibitor;
ion transport inhibitor;
loop diuretic |
| k-strophanthin-beta | [no description available] | medium | 1 | 0 | cardenolide glycoside;
steroid aldehyde | |
| 1-naphthylisothiocyanate | [no description available] | medium | 1 | 0 | isothiocyanate | insecticide |
| aluminum sulfate | [no description available] | medium | 1 | 0 | aluminium sulfate | |
| hydrochloric acid | [no description available] | medium | 2 | 0 | chlorine molecular entity;
gas molecular entity;
hydrogen halide;
mononuclear parent hydride | mouse metabolite |
| 4-aminopyridine | [no description available] | medium | 1 | 0 | aminopyridine;
aromatic amine | avicide;
orphan drug;
potassium channel blocker |
| diazoxide | [no description available] | medium | 1 | 0 | benzothiadiazine;
organochlorine compound;
sulfone | antihypertensive agent;
beta-adrenergic agonist;
bronchodilator agent;
cardiotonic drug;
diuretic;
K-ATP channel agonist;
sodium channel blocker;
sympathomimetic agent;
vasodilator agent |
| atropine | [no description available] | medium | 3 | 0 | | |
| amifampridine | [no description available] | medium | 1 | 0 | aminopyridine | |
| amiloride | [no description available] | medium | 4 | 0 | aromatic amine;
guanidines;
organochlorine compound;
pyrazines | diuretic;
sodium channel blocker |
| 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein | [no description available] | medium | 1 | 0 | | |
| adenosine diphosphate | [no description available] | medium | 2 | 0 | adenosine 5'-phosphate;
purine ribonucleoside 5'-diphosphate | fundamental metabolite;
human metabolite |
| lysine | [no description available] | medium | 1 | 0 | aspartate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
lysine;
organic molecular entity;
proteinogenic amino acid | algal metabolite;
anticonvulsant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite |
| uridine triphosphate | [no description available] | medium | 1 | 0 | pyrimidine ribonucleoside 5'-triphosphate;
uridine 5'-phosphate | Escherichia coli metabolite;
mouse metabolite |
| taurine | [no description available] | medium | 3 | 0 | amino sulfonic acid;
zwitterion | antioxidant;
Escherichia coli metabolite;
glycine receptor agonist;
human metabolite;
mouse metabolite;
nutrient;
radical scavenger;
Saccharomyces cerevisiae metabolite |
| gallic acid | [no description available] | medium | 1 | 0 | trihydroxybenzoic acid | antineoplastic agent;
antioxidant;
apoptosis inducer;
astringent;
cyclooxygenase 2 inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
geroprotector;
human xenobiotic metabolite;
plant metabolite |
| 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate | [no description available] | medium | 1 | 0 | trihydroxybenzoic acid | |
| arginine vasopressin | [no description available] | medium | 2 | 0 | vasopressin | cardiovascular drug;
hematologic agent;
mitogen |
| lanthanum trifluoride | [no description available] | medium | 1 | 0 | | |
| ethidium homodimer | [no description available] | medium | 1 | 0 | | |
| texas red | [no description available] | medium | 1 | 0 | organic heteroheptacyclic compound | fluorochrome |
| acridine orange | [no description available] | medium | 1 | 0 | aminoacridines;
aromatic amine;
tertiary amino compound | fluorochrome;
histological dye |
| melitten | [no description available] | medium | 1 | 0 | | |
| adenylyl-(3'-5')-adenosine | [no description available] | medium | 1 | 0 | | |
| sucrose | [no description available] | medium | 2 | 0 | glycosyl glycoside | algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
sweetening agent |
| wortmannin | [no description available] | medium | 1 | 0 | acetate ester;
cyclic ketone;
delta-lactone;
organic heteropentacyclic compound | anticoronaviral agent;
antineoplastic agent;
autophagy inhibitor;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
geroprotector;
Penicillium metabolite;
radiosensitizing agent |
| tyrosine | [no description available] | medium | 1 | 0 | amino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
tyrosine | EC 1.3.1.43 (arogenate dehydrogenase) inhibitor;
fundamental metabolite;
micronutrient;
nutraceutical |
| econazole | [no description available] | medium | 1 | 0 | dichlorobenzene;
ether;
imidazoles;
monochlorobenzenes | |
| miconazole | [no description available] | medium | 1 | 0 | dichlorobenzene;
ether;
imidazoles | |
| brassinolide | [no description available] | medium | 1 | 0 | 22-hydroxy steroid;
23-hydroxy steroid;
2alpha-hydroxy steroid;
3alpha-hydroxy steroid;
brassinosteroid | plant growth stimulator;
plant hormone |
| staurosporine | [no description available] | medium | 5 | 0 | ammonium ion derivative | |
| indoleacetic acid | [no description available] | medium | 2 | 0 | indole-3-acetic acids;
monocarboxylic acid | auxin;
human metabolite;
mouse metabolite;
plant hormone;
plant metabolite |
| 1,3-dipropyl-8-cyclopentylxanthine | [no description available] | medium | 1 | 0 | oxopurine | adenosine A1 receptor antagonist;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor |
| adenosine | [no description available] | medium | 2 | 0 | adenosines;
purines D-ribonucleoside | analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent |
| guanosine 5'-o-(3-thiotriphosphate) | [no description available] | medium | 1 | 0 | nucleoside triphosphate analogue | |
| n(6)-cyclopentyladenosine | [no description available] | medium | 1 | 0 | | |
| mannitol | [no description available] | medium | 1 | 0 | mannitol | allergen;
antiglaucoma drug;
compatible osmolytes;
Escherichia coli metabolite;
food anticaking agent;
food bulking agent;
food humectant;
food stabiliser;
food thickening agent;
hapten;
metabolite;
osmotic diuretic;
sweetening agent |
| camptothecin | [no description available] | medium | 2 | 0 | delta-lactone;
pyranoindolizinoquinoline;
quinoline alkaloid;
tertiary alcohol | antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
genotoxin;
plant metabolite |
| 2,5-norbornadiene | [no description available] | medium | 1 | 0 | | |
| 1-aminocyclopropane-1-carboxylic acid | [no description available] | medium | 1 | 0 | amino acid zwitterion;
monocarboxylic acid;
non-proteinogenic alpha-amino acid | ethylene releasers;
plant metabolite |
| 2,2-bis(bromomethyl)-1,3-propanediol | [no description available] | medium | 1 | 0 | primary alcohol | |
| neutral red | [no description available] | medium | 1 | 0 | hydrochloride | acid-base indicator;
dye;
two-colour indicator |
| tert-butylbicyclophosphorothionate | [no description available] | medium | 1 | 0 | organic thiophosphate | |
| cellulose | [no description available] | medium | 1 | 0 | glycoside | |
| quinine | [no description available] | medium | 1 | 0 | cinchona alkaloid | antimalarial;
muscle relaxant;
non-narcotic analgesic |
| alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid | [no description available] | medium | 1 | 0 | non-proteinogenic alpha-amino acid | |
| 6-cyano-7-nitroquinoxaline-2,3-dione | [no description available] | medium | 1 | 0 | quinoxaline derivative | |
| gyki 53655 | [no description available] | medium | 1 | 0 | | |
| aminoethoxyvinylglycine | [no description available] | medium | 1 | 0 | | |
| aspartic acid | [no description available] | medium | 1 | 0 | aspartate family amino acid;
aspartic acid;
L-alpha-amino acid;
proteinogenic amino acid | Escherichia coli metabolite;
mouse metabolite;
neurotransmitter |
| glycine | [no description available] | medium | 1 | 0 | alpha-amino acid;
amino acid zwitterion;
proteinogenic amino acid;
serine family amino acid | EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor;
fundamental metabolite;
hepatoprotective agent;
micronutrient;
neurotransmitter;
NMDA receptor agonist;
nutraceutical |
| tosyllysine chloromethyl ketone | [no description available] | medium | 1 | 0 | sulfonic acid derivative | |
| p-methoxy-n-methylphenethylamine | [no description available] | medium | 1 | 0 | aromatic ether;
secondary amino compound | metabolite |
| rubidium | [no description available] | medium | 1 | 0 | alkali metal atom | |
| antipain | [no description available] | medium | 1 | 0 | | |
| leupeptin | [no description available] | medium | 1 | 0 | aldehyde;
tripeptide | bacterial metabolite;
calpain inhibitor;
cathepsin B inhibitor;
EC 3.4.21.4 (trypsin) inhibitor;
serine protease inhibitor |
| leupeptins | [no description available] | medium | 1 | 0 | | |
| methionine | [no description available] | medium | 2 | 0 | aspartate family amino acid;
L-alpha-amino acid;
methionine zwitterion;
methionine;
proteinogenic amino acid | antidote to paracetamol poisoning;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical |
| losartan | [no description available] | medium | 1 | 0 | biphenylyltetrazole;
imidazoles | angiotensin receptor antagonist;
anti-arrhythmia drug;
antihypertensive agent;
endothelin receptor antagonist |
| gramicidin a | [no description available] | medium | 1 | 0 | | |
| sulfur | [no description available] | medium | 1 | 0 | chalcogen;
nonmetal atom | macronutrient |
| lithium chloride | [no description available] | medium | 1 | 0 | inorganic chloride;
lithium salt | antimanic drug;
geroprotector |
| aluminum chloride | [no description available] | medium | 2 | 0 | aluminium coordination entity | Lewis acid |
| atrial natriuretic factor | [no description available] | medium | 2 | 0 | polypeptide | |
| w 7 | [no description available] | medium | 3 | 0 | | |
| 1-(5-isoquinolinesulfonyl)-2-methylpiperazine | [no description available] | medium | 2 | 0 | isoquinolines;
N-sulfonylpiperazine | EC 2.7.11.13 (protein kinase C) inhibitor |
| g(m1) ganglioside | [no description available] | medium | 2 | 0 | alpha-N-acetylneuraminosyl-(2->3)-[beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphingosine;
sialotetraosylceramide | |
| beta carotene | [no description available] | medium | 1 | 0 | carotenoid beta-end derivative;
cyclic carotene | antioxidant;
biological pigment;
cofactor;
ferroptosis inhibitor;
human metabolite;
mouse metabolite;
plant metabolite;
provitamin A |
| rotenone | [no description available] | medium | 1 | 0 | organic heteropentacyclic compound;
rotenones | antineoplastic agent;
metabolite;
mitochondrial NADH:ubiquinone reductase inhibitor;
phytogenic insecticide;
piscicide;
toxin |
| methacycline | [no description available] | medium | 1 | 0 | 1,2-diglyceride | |
| 1-hexadecyl-2-acetyl-glycero-3-phosphocholine | [no description available] | medium | 1 | 0 | 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine | antihypertensive agent;
beta-adrenergic antagonist;
bronchoconstrictor agent;
hematologic agent;
vasodilator agent |
| dinoprost | [no description available] | medium | 2 | 0 | monocarboxylic acid;
prostaglandins Falpha | human metabolite;
mouse metabolite |
| 5,5'-dimethyl-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetate | [no description available] | medium | 1 | 0 | polyamino carboxylic acid | chelator |
| ferric chloride | [no description available] | medium | 1 | 0 | iron coordination entity | astringent;
Lewis acid |
| gallium | [no description available] | medium | 1 | 0 | boron group element atom | |
| gallium nitrate | [no description available] | medium | 1 | 0 | | |
| glutaral | [no description available] | medium | 1 | 0 | dialdehyde | cross-linking reagent;
disinfectant;
fixative |
| tetradecanoylphorbol acetate | [no description available] | medium | 3 | 0 | acetate ester;
diester;
phorbol ester;
tertiary alpha-hydroxy ketone;
tetradecanoate ester | antineoplastic agent;
apoptosis inducer;
carcinogenic agent;
mitogen;
plant metabolite;
protein kinase C agonist;
reactive oxygen species generator |
| thymidine | [no description available] | medium | 2 | 0 | pyrimidine 2'-deoxyribonucleoside | Escherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite |
| nitrendipine | [no description available] | medium | 1 | 0 | C-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
ethyl ester;
methyl ester | antihypertensive agent;
calcium channel blocker;
geroprotector;
vasodilator agent |
| propranolol | [no description available] | medium | 1 | 0 | naphthalenes;
propanolamine;
secondary amine | anti-arrhythmia drug;
antihypertensive agent;
anxiolytic drug;
beta-adrenergic antagonist;
environmental contaminant;
human blood serum metabolite;
vasodilator agent;
xenobiotic |
| 1,2-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetic acid | [no description available] | medium | 1 | 0 | polyamino carboxylic acid;
tetracarboxylic acid | chelator |
| trimethylamine | [no description available] | medium | 1 | 0 | methylamines;
tertiary amine | Escherichia coli metabolite;
human xenobiotic metabolite |
| farnesoic acid | [no description available] | medium | 1 | 0 | farnesoic acid | animal metabolite |
| guanosine triphosphate | [no description available] | medium | 1 | 0 | guanosine 5'-phosphate;
purine ribonucleoside 5'-triphosphate | Escherichia coli metabolite;
mouse metabolite;
uncoupling protein inhibitor |
| cytidine triphosphate | [no description available] | medium | 1 | 0 | cytidine 5'-phosphate;
pyrimidine ribonucleoside 5'-triphosphate | Escherichia coli metabolite;
mouse metabolite |
| caffeine | [no description available] | medium | 1 | 0 | purine alkaloid;
trimethylxanthine | adenosine A2A receptor antagonist;
adenosine receptor antagonist;
adjuvant;
central nervous system stimulant;
diuretic;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
environmental contaminant;
food additive;
fungal metabolite;
geroprotector;
human blood serum metabolite;
mouse metabolite;
mutagen;
plant metabolite;
psychotropic drug;
ryanodine receptor agonist;
xenobiotic |
| acid phosphatase | [no description available] | medium | 1 | 0 | | |
| pyrroles | [no description available] | medium | 1 | 0 | pyrrole;
secondary amine | |
| kt 5720 | [no description available] | medium | 1 | 0 | carboxylic ester;
gamma-lactam;
hemiaminal;
indolocarbazole;
organic heterooctacyclic compound;
semisynthetic derivative;
tertiary alcohol | EC 2.7.11.11 (cAMP-dependent protein kinase) inhibitor |
| gallopamil | [no description available] | medium | 2 | 0 | benzenes;
organic amino compound | |
| monensin | [no description available] | medium | 1 | 0 | cyclic hemiketal;
monocarboxylic acid;
polyether antibiotic;
spiroketal | antifungal agent;
coccidiostat;
ionophore |
| benzofurans | [no description available] | medium | 1 | 0 | | |
| phenothiazine | [no description available] | medium | 1 | 0 | phenothiazine | ferroptosis inhibitor;
plant metabolite;
radical scavenger |
| enkephalin, methionine | [no description available] | medium | 1 | 0 | | |
| pn 202-791 | [no description available] | medium | 1 | 0 | benzoxadiazole;
isopropyl ester | |
| substance p | [no description available] | medium | 1 | 0 | peptide | neurokinin-1 receptor agonist;
neurotransmitter;
vasodilator agent |
| alcian blue | [no description available] | medium | 1 | 0 | | |
| carbonyl cyanide m-chlorophenyl hydrazone | [no description available] | medium | 1 | 0 | hydrazone;
monochlorobenzenes;
nitrile | antibacterial agent;
geroprotector;
ionophore |
| pyrophosphate | [no description available] | medium | 1 | 0 | diphosphate ion | |
| sodium pyrophosphate | [no description available] | medium | 1 | 0 | inorganic sodium salt | chelator;
food emulsifier;
food thickening agent |
| dinoprostone | [no description available] | medium | 2 | 0 | prostaglandins E | human metabolite;
mouse metabolite;
oxytocic |
| calcitriol | [no description available] | medium | 1 | 0 | D3 vitamins;
hydroxycalciol;
triol | antineoplastic agent;
antipsoriatic;
bone density conservation agent;
calcium channel agonist;
calcium channel modulator;
hormone;
human metabolite;
immunomodulator;
metabolite;
mouse metabolite;
nutraceutical |
| sincalide | [no description available] | medium | 2 | 0 | oligopeptide | |
| acetic acid | [no description available] | medium | 1 | 0 | monocarboxylic acid | antimicrobial food preservative;
Daphnia magna metabolite;
food acidity regulator;
protic solvent |
| 5-dimethylamiloride | [no description available] | medium | 1 | 0 | | |
| bromodeoxycytidine | [no description available] | medium | 1 | 0 | | |
| idoxuridine | [no description available] | medium | 1 | 0 | organoiodine compound;
pyrimidine 2'-deoxyribonucleoside | antiviral drug;
DNA synthesis inhibitor |
| deoxycytidine | [no description available] | medium | 1 | 0 | pyrimidine 2'-deoxyribonucleoside | Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite |
| ibacitabine | [no description available] | medium | 1 | 0 | pyrimidine 2'-deoxyribonucleoside | |
| hemicholinium 3 | [no description available] | medium | 2 | 0 | | |
| phorbol 12,13-dibutyrate | [no description available] | medium | 1 | 0 | butyrate ester;
phorbol ester;
tertiary alpha-hydroxy ketone | |
| glycerophosphoinositol 4,5-bisphosphate | [no description available] | medium | 1 | 0 | | |
| corticosterone | [no description available] | medium | 1 | 0 | 11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone | human metabolite;
mouse metabolite |
| cosyntropin | [no description available] | medium | 1 | 0 | | |
| phenytoin | [no description available] | medium | 1 | 0 | imidazolidine-2,4-dione | anticonvulsant;
drug allergen;
sodium channel blocker;
teratogenic agent |
| anisomycin | [no description available] | medium | 2 | 0 | monohydroxypyrrolidine;
organonitrogen heterocyclic antibiotic | anticoronaviral agent;
antimicrobial agent;
antineoplastic agent;
antiparasitic agent;
bacterial metabolite;
DNA synthesis inhibitor;
protein synthesis inhibitor |
| gamma-glutamylglycine | [no description available] | medium | 1 | 0 | | |
| benzoic acid | [no description available] | medium | 1 | 0 | benzoic acids | algal metabolite;
antimicrobial food preservative;
drug allergen;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 3.1.1.3 (triacylglycerol lipase) inhibitor;
human xenobiotic metabolite;
plant metabolite |
| morphine | [no description available] | medium | 1 | 0 | morphinane alkaloid;
organic heteropentacyclic compound;
tertiary amino compound | anaesthetic;
drug allergen;
environmental contaminant;
geroprotector;
mu-opioid receptor agonist;
opioid analgesic;
plant metabolite;
vasodilator agent;
xenobiotic |
| dithiothreitol | [no description available] | medium | 1 | 0 | 1,4-dimercaptobutane-2,3-diol;
butanediols;
dithiol;
glycol;
thiol | chelator;
human metabolite;
reducing agent |
| lead | [no description available] | medium | 1 | 0 | carbon group element atom;
elemental lead;
metal atom | neurotoxin |
| valproic acid | [no description available] | medium | 1 | 0 | branched-chain fatty acid;
branched-chain saturated fatty acid | anticonvulsant;
antimanic drug;
EC 3.5.1.98 (histone deacetylase) inhibitor;
GABA agent;
neuroprotective agent;
psychotropic drug;
teratogenic agent |
| choline | [no description available] | medium | 2 | 0 | cholines | allergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter;
nutrient;
plant metabolite;
Saccharomyces cerevisiae metabolite |
| technetium | [no description available] | medium | 1 | 0 | manganese group element atom | |
| hematoporphyrin | [no description available] | medium | 1 | 0 | | |
| dihydroergotamine | [no description available] | medium | 1 | 0 | ergot alkaloid;
semisynthetic derivative | dopamine agonist;
non-narcotic analgesic;
serotonergic agonist;
sympatholytic agent;
vasoconstrictor agent |
| zirconium | [no description available] | medium | 1 | 0 | titanium group element atom | |